Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mirochnick

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Pediatrics|July 1, 1996
Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performanceE Z Tronick, D A Frank, H Cabral, et al.
The Journal of Pediatrics|May 1, 1993
Pharmacokinetics of dapsone in childrenM Mirochnick, M Michaels, D Clarke, et al.
Clinical Pediatrics|November 24, 1998
Blood pressure in children exposed prenatally to cocaineR Needlman, D A Frank, H Cabral, et al.
Pediatrics|April 1, 1997
Elevated plasma norepinephrine after in utero exposure to cocaine and marijuanaM Mirochnick, J Meyer, D A Frank, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virusM Mirochnick, E Capparelli, W Dankner, et al.
Pediatrics|November 5, 1999
Level of in utero cocaine exposure and neonatal ultrasound findingsD A Frank, K M McCarten, C D Robson, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
From pediatric covariate model to semiphysiological function for maturation: part I-extrapolation of a covariate model from morphine to ZidovudineE H J Krekels, M Neely, E Panoilia, et al.
The Journal of Pediatrics|January 1, 1993
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virusF D Boucher, J F Modlin, S Weller, et al.
HIV Medicine|December 17, 2009
Lopinavir protein binding in HIV-1-infected pregnant womenF T Aweeka, A Stek, B M Best, et al.
AIDS (London, England)|September 13, 2000
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmissionJ B Jackson, G Becker-Pergola, L A Guay, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Pediatrics|July 1, 1996
Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performanceE Z Tronick, D A Frank, H Cabral, et al.
The Journal of Pediatrics|May 1, 1993
Pharmacokinetics of dapsone in childrenM Mirochnick, M Michaels, D Clarke, et al.
Clinical Pediatrics|November 24, 1998
Blood pressure in children exposed prenatally to cocaineR Needlman, D A Frank, H Cabral, et al.
Pediatrics|April 1, 1997
Elevated plasma norepinephrine after in utero exposure to cocaine and marijuanaM Mirochnick, J Meyer, D A Frank, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virusM Mirochnick, E Capparelli, W Dankner, et al.
Pediatrics|November 5, 1999
Level of in utero cocaine exposure and neonatal ultrasound findingsD A Frank, K M McCarten, C D Robson, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
From pediatric covariate model to semiphysiological function for maturation: part I-extrapolation of a covariate model from morphine to ZidovudineE H J Krekels, M Neely, E Panoilia, et al.
The Journal of Pediatrics|January 1, 1993
Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virusF D Boucher, J F Modlin, S Weller, et al.
HIV Medicine|December 17, 2009
Lopinavir protein binding in HIV-1-infected pregnant womenF T Aweeka, A Stek, B M Best, et al.
AIDS (London, England)|September 13, 2000
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmissionJ B Jackson, G Becker-Pergola, L A Guay, et al.
Pageof 4